Wang et al. showed that negative SCC-Ag and CYFRA 21-1 are associated with EGFR mutation status, and combined gender and histology may enhance the ability of NSCLC patients to distinguish EGFR mutation status [21]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.